Meeting of the Secretary's Advisory Committee on Genetic Testing

[Federal Register Volume 64, Number 181 (Monday, September 20, 1999)]
[Notices]
[Pages 50816-50817]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-24376]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Office of the Secretary


Meeting of the Secretary's Advisory Committee on Genetic Testing

AGENCY: Office of the Secretary, DHHS.

ACTION: Notice of meeting.

-----------------------------------------------------------------------

    Pursuant to Public Law 92-463, notice is hereby given of a meeting 
of the Secretary's Advisory Committee on Genetic Testing (SACGT), U.S. 
Public Health Service. The meeting will be held at the Doubletree 
Hotel, Regency Ballroom, 1750 Rockville Pike, Bethesda, MD 20852, 
starting on October 25, 1999 at approximately 9:00 a.m. and will recess 
at approximately 5:30 p.m. The meeting will reconvene on October 26, 
1999 at approximately 8:00 a.m. and will adjourn at approximately 5:00 
p.m. The meeting will be open to the public. Attendance by the public 
will be limited by the space available. The committee will continue 
deliberations begun at its first meeting in June on questions related 
to the oversight of genetic testing, and it will finalize plans for 
gathering public perspectives on those questions. A limited period of 
time will be provided for public comment, and individuals

[[Page 50817]]

interested in participating in the public comment period should contact 
Ms. Sarah Carr, SACGT Executive Secretary, as shown below.
    Under authority of 42 U.S.C. 217a, Section 222 of the Public Health 
Service Act, as amended, the Department of Health and Human Services 
(DHHS) established the SACGT to advise and make recommendations to the 
Secretary through the Assistant Secretary for Health on all aspects of 
the development and use of genetic tests. The SACGT is directed to: (1) 
Recommended policies and procedures for the safe and effective 
incorporation of genetic technologies into health care; (2) assess the 
effectiveness of existing and future measures for oversight of genetic 
tests; (3) and identify research needs related to the Committee's 
purview.
    Further information about the SACGT is available at the following 
web site: www.nih.gov/od/orda/sacgtdocs.htm. A draft meeting 
agenda will be posted to the site prior to the meeting. Individuals who 
wish to provide public comments should notify Ms. Carr, by telephone at 
301-496-9838 or E-mail at sc112c@nih.gov as soon as possible and 
provide a copy of their remarks to Ms. Carr by October 15, 1999. Those 
who plan to attend the meeting and need special assistance, such as 
sign language interpretation or other reasonable accommodations, should 
notify Ms. Carr at 301-496-9838. The SACGT office is located at 6000 
Executive Boulevard, Suite 302, Bethesda, Maryland 20892.

    Dated: September 13, 1999.
Sarah Carr,
Executive Secretary, SACGT.
[FR Doc. 99-24376 Filed 9-17-99; 8:45 am]
BILLING CODE 4140-01-M